| |
| |
|
| Insider
Information: |
Heiden William K |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
788,112 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,998,616 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
788,112 |
|
|
| Total
Value |
$5,998,616 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 129.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
President & CEO, Direc... |
2020-03-02 |
424,612 |
2012-05-24 |
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2024-03-31 |
359,000 |
2017-01-03 |
0 |
Premium* |
|
|
Macrogenics Inc |
MGNX |
Director |
2024-05-20 |
4,500 |
2024-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMAG |
AMAG Pharmaceuticals Inc |
President & CEO |
• • – |
2019-05-09 |
4 |
B |
$10.70 |
$107,000 |
D/D |
10,000 |
490,056 |
2.81 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & CEO |
• • – |
2018-03-02 |
4 |
D |
$21.00 |
$221,466 |
D/D |
(10,546) |
353,015 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
31,500 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2015-06-02 |
4 |
D |
$67.77 |
$771,087 |
D/D |
(11,378) |
215,596 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2016-05-16 |
4 |
A |
$18.27 |
$215,805 |
D/D |
11,812 |
206,646 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2016-02-26 |
4 |
D |
$27.01 |
$397,560 |
D/D |
(14,719) |
186,002 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President and CEO |
• • – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,600 |
169,338 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & CEO |
• • – |
2017-05-08 |
4 |
D |
$18.55 |
$354,027 |
D/D |
(19,085) |
272,561 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2015-07-15 |
4 |
AS |
$75.00 |
$1,500,000 |
D/D |
(20,000) |
206,721 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2015-07-15 |
4 |
OE |
$12.99 |
$259,800 |
D/D |
20,000 |
226,721 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & CEO |
• • – |
2018-06-04 |
4 |
AS |
$25.00 |
$500,000 |
D/D |
(20,000) |
333,015 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,500 |
52,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President and CEO |
• • – |
2013-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
76,900 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President and CEO |
• • – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
229,448 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2016-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
218,458 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President and CEO |
• • – |
2014-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
209,338 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President and CEO |
• • – |
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
41,900 |
51,900 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
57,000 |
109,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2015-06-05 |
4 |
OE |
$12.99 |
$779,400 |
D/D |
60,000 |
268,721 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2015-06-05 |
4 |
AS |
$68.14 |
$4,674,414 |
D/D |
(66,875) |
208,721 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CEO |
• • – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
291,646 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & CEO |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
91,000 |
363,561 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2023-11-10 |
4 |
B |
$0.25 |
$25,330 |
D/D |
100,000 |
209,000 |
0.01 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
359,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
President & CEO |
• • – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
163,000 |
488,058 |
0 |
- |
|
50 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
